US officials threaten to sanction firm that promised to revolutionize blood testingBMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2189 (Published 15 April 2016) Cite this as: BMJ 2016;353:i2189
- Michael McCarthy
US regulators have proposed revoking the federal license of the California laboratory of the biotechnology firm Theranos and banning the company’s top officials from owning or running a laboratory for at least two years.
The privately held company had promised to revolutionize the blood testing industry with a technology that the company said made it possible to run various tests for a wide variety of conditions from only few drops of blood collected with a simple finger prick. With the claim that its technology would make blood testing faster, cheaper, less painful, and more …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial